Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Drug-drug Interaction Study Between KD025, Itraconazole, Rifampicin, Rabeprazole and Omeprazole in Healthy Volunteers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03530995
Recruitment Status : Recruiting
First Posted : May 21, 2018
Last Update Posted : October 15, 2018
Sponsor:
Collaborator:
Quotient Sciences
Information provided by (Responsible Party):
Kadmon Corporation, LLC

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : March 15, 2019
  Estimated Study Completion Date : June 15, 2019